Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Plasma-derived Therapies industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Bayer
LFB
Bio Products Laboratory (BPL)
Grifols
Kedrion
Takeda
Shire
CSL Behring LLC
Octaparma
By Type:
Immunoglobulin
Albumin
Factor VIII
Others
By Application:
Hemophilia
Primary Immunodeficiencies (PIDs)
Idiopathic Thrombocytopenic Purpura (ITP)
Others
COVID-19
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Plasma-derived Therapies Market Overview 2018-2029
-
1.1 China Plasma-derived Therapies Industry Development Overview
-
1.2 China Plasma-derived Therapies Industry Development History
-
1.3 China Plasma-derived Therapies Industry Market Size (2018-2029)
-
1.4 China Plasma-derived Therapies Market Analysis by Type from Production Side
-
1.4.1 China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Immunoglobulin (2018-2029)
-
1.4.2 China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Albumin (2018-2029)
-
1.4.3 China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Factor VIII (2018-2029)
-
1.4.4 China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.5 China Plasma-derived Therapies Market Analysis by Application from Consumption End
-
1.5.1 China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)
-
1.5.2 China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Primary Immunodeficiencies (PIDs) (2018-2029)
-
1.5.3 China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Idiopathic Thrombocytopenic Purpura (ITP) (2018-2029)
-
1.5.4 China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
1.5.5 China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of COVID-19 (2018-2029)
-
1.6 China Plasma-derived Therapies Market Analysis by Region
-
1.6.1 North China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
Chapter 2 China Plasma-derived Therapies Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Plasma-derived Therapies Market Status and Competition at home and abroad in 2023
-
2.2.2 China Plasma-derived Therapies Market Status and Competition Analysis in 2023
-
2.2.3 China Plasma-derived Therapies Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Plasma-derived Therapies Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Plasma-derived Therapies Industry Development
Chapter 3 Plasma-derived TherapiesIndustry Chain Analysis
-
3.1 Plasma-derived Therapies Industry Chain
-
3.2 Plasma-derived Therapies Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Plasma-derived Therapies Market
-
3.3 Plasma-derived Therapies Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Plasma-derived Therapies Market
Chapter 4 China Plasma-derived Therapies Market, by Type
-
4.1 China Plasma-derived Therapies Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Plasma-derived Therapies Total Production Volume and Growth Rate from Production Side
-
4.5 China Plasma-derived Therapies Production Volume and Growth Rate, by Type
-
4.5.1 China Plasma-derived Therapies Production Volume and Growth Rate of Immunoglobulin
-
4.5.2 China Plasma-derived Therapies Production Volume and Growth Rate of Albumin
-
4.5.3 China Plasma-derived Therapies Production Volume and Growth Rate of Factor VIII
-
4.5.4 China Plasma-derived Therapies Production Volume and Growth Rate of Others
Chapter 5 China Plasma-derived Therapies Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Plasma-derived Therapies Total Market Size and Growth Rate from Consumption End
-
5.5 China Plasma-derived Therapies Market Size and Growth Rate, by Application
-
5.5.1 China Plasma-derived Therapies Market Size and Growth Rate of Hemophilia
-
5.5.2 China Plasma-derived Therapies Market Size and Growth Rate of Primary Immunodeficiencies (PIDs)
-
5.5.3 China Plasma-derived Therapies Market Size and Growth Rate of Idiopathic Thrombocytopenic Purpura (ITP)
-
5.5.4 China Plasma-derived Therapies Market Size and Growth Rate of Others
-
5.5.5 China Plasma-derived Therapies Market Size and Growth Rate of COVID-19
Chapter 6 China Plasma-derived Therapies Market, by Region
-
6.1 China Plasma-derived Therapies Production Volume and Production Value, by Region
-
6.2 China Plasma-derived Therapies Sales Volume and Sales Value, by Region
Chapter 7 North China Plasma-derived Therapies Market Analysis
-
7.1 North China Plasma-derived Therapies Market, by Type
-
7.2 North China Plasma-derived Therapies Market, by Application
Chapter 8 Central China Plasma-derived Therapies Market Analysis
-
8.1 Central China Plasma-derived Therapies Market, by Type
-
8.2 Central China Plasma-derived Therapies Market, by Application
Chapter 9 South China Plasma-derived Therapies Market Analysis
-
9.1 South China Plasma-derived Therapies Market, by Type
-
9.2 South China Plasma-derived Therapies Market, by Application
Chapter 10 East China Plasma-derived Therapies Market Analysis
-
10.1 East China Plasma-derived Therapies Market, by Type
-
10.2 East China Plasma-derived Therapies Market, by Application
Chapter 11 Northeast China Plasma-derived Therapies Market Analysis
-
11.1 Northeast China Plasma-derived Therapies Market, by Type
-
11.2 Northeast China Plasma-derived Therapies Market, by Application
Chapter 12 Southwest China Plasma-derived Therapies Market Analysis
-
12.1 Southwest China Plasma-derived Therapies Market, by Type
-
12.2 Southwest China Plasma-derived Therapies Market, by Application
Chapter 13 Northwest China Plasma-derived Therapies Market Analysis
-
13.1 Northwest China Plasma-derived Therapies Market, by Type
-
13.2 Northwest China Plasma-derived Therapies Market, by Application
Chapter 14 Company Profiles
-
14.1 Bayer
-
14.1.1 Bayer Company Profile
-
14.1.2 Bayer Plasma-derived Therapies Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 LFB
-
14.2.1 LFB Company Profile
-
14.2.2 LFB Plasma-derived Therapies Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Bio Products Laboratory (BPL)
-
14.3.1 Bio Products Laboratory (BPL) Company Profile
-
14.3.2 Bio Products Laboratory (BPL) Plasma-derived Therapies Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Grifols
-
14.4.1 Grifols Company Profile
-
14.4.2 Grifols Plasma-derived Therapies Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Kedrion
-
14.5.1 Kedrion Company Profile
-
14.5.2 Kedrion Plasma-derived Therapies Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Takeda
-
14.6.1 Takeda Company Profile
-
14.6.2 Takeda Plasma-derived Therapies Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Shire
-
14.7.1 Shire Company Profile
-
14.7.2 Shire Plasma-derived Therapies Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 CSL Behring LLC
-
14.8.1 CSL Behring LLC Company Profile
-
14.8.2 CSL Behring LLC Plasma-derived Therapies Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Octaparma
-
14.9.1 Octaparma Company Profile
-
14.9.2 Octaparma Plasma-derived Therapies Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Plasma-derived Therapies Industry Research Conclusions
-
15.2 Plasma-derived Therapies Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Plasma-derived Therapies Industry Market Size (2018-2029)
-
Figure China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Immunoglobulin (2018-2029)
-
Figure China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Albumin (2018-2029)
-
Figure China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Factor VIII (2018-2029)
-
Figure China Plasma-derived Therapies Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Hemophilia (2018-2029)
-
Figure China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Primary Immunodeficiencies (PIDs) (2018-2029)
-
Figure China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Idiopathic Thrombocytopenic Purpura (ITP) (2018-2029)
-
Figure China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of Others (2018-2029)
-
Figure China Plasma-derived Therapies Sales Volume, Sales Value and Growth Rate of COVID-19 (2018-2029)
-
Figure North China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure Central China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure South China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure East China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Plasma-derived Therapies Market Size and Growth Rate from 2018-2029
-
Figure Plasma-derived Therapies Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Plasma-derived Therapies Market Share by Type in 2018
-
Figure China Plasma-derived Therapies Market Share by Type in 2023
-
Figure China Plasma-derived Therapies Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Plasma-derived Therapies Production Volume and Growth Rate of Immunoglobulin (2018-2023)
-
Figure China Plasma-derived Therapies Production Volume and Growth Rate of Albumin (2018-2023)
-
Figure China Plasma-derived Therapies Production Volume and Growth Rate of Factor VIII (2018-2023)
-
Figure China Plasma-derived Therapies Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Plasma-derived Therapies Market Share by Application in 2018
-
Figure China Plasma-derived Therapies Market Share by Application in 2023
-
Figure China Plasma-derived Therapies Total Market Size and Growth Rate from Consumption End
-
Figure China Plasma-derived Therapies Market Size and Growth Rate of Hemophilia (2018-2023)
-
Figure China Plasma-derived Therapies Market Size and Growth Rate of Primary Immunodeficiencies (PIDs) (2018-2023)
-
Figure China Plasma-derived Therapies Market Size and Growth Rate of Idiopathic Thrombocytopenic Purpura (ITP) (2018-2023)
-
Figure China Plasma-derived Therapies Market Size and Growth Rate of Others (2018-2023)
-
Figure China Plasma-derived Therapies Market Size and Growth Rate of COVID-19 (2018-2023)
-
Table China Plasma-derived Therapies Production Volume by Region (2018-2023)
-
Table China Plasma-derived Therapies Production Volume Share by Region (2018-2023)
-
Figure China Plasma-derived Therapies Production Volume Share by Region (2018-2023)
-
Table China Plasma-derived Therapies Production Value by Region (2018-2023)
-
Table China Plasma-derived Therapies Production Value Share by Region (2018-2023)
-
Figure China Plasma-derived Therapies Production Value Share by Region (2018-2023)
-
Table China Plasma-derived Therapies Sales Volume by Region (2018-2023)
-
Table China Plasma-derived Therapies Sales Volume Share by Region (2018-2023)
-
Figure China Plasma-derived Therapies Sales Volume Share by Region (2018-2023)
-
Table China Plasma-derived Therapies Sales Value by Region (2018-2023)
-
Table China Plasma-derived Therapies Sales Value Share by Region (2018-2023)
-
Figure China Plasma-derived Therapies Sales Value Share by Region (2018-2023)
-
Table North China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table North China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure North China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table North China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table North China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure North China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table Central China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table Central China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure Central China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table Central China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table Central China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure Central China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table South China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table South China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure South China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table South China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table South China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure South China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table East China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table East China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure East China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table East China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table East China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure East China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table Northeast China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table Northeast China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure Northeast China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table Northeast China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table Northeast China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table Southwest China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table Southwest China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure Southwest China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table Southwest China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table Southwest China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table Northwest China Plasma-derived Therapies Production Volume by Type (2018-2023)
-
Table Northwest China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Figure Northwest China Plasma-derived Therapies Production Volume Share by Type (2018-2023)
-
Table Northwest China Plasma-derived Therapies Sales Volume by Application (2018-2023)
-
Table Northwest China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Plasma-derived Therapies Sales Volume Share by Application (2018-2023)
-
Table Bayer Company Profile
-
Table Bayer Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table LFB Company Profile
-
Table LFB Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Bio Products Laboratory (BPL) Company Profile
-
Table Bio Products Laboratory (BPL) Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Grifols Company Profile
-
Table Grifols Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Kedrion Company Profile
-
Table Kedrion Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Shire Company Profile
-
Table Shire Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table CSL Behring LLC Company Profile
-
Table CSL Behring LLC Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
Table Octaparma Company Profile
-
Table Octaparma Plasma-derived Therapies Revenue, Price and Gross (2018-2023)
-
